Cargando…

Predictive accuracy of T2-FLAIR mismatch sign for the IDH-mutant, 1p/19q noncodeleted low-grade glioma: An updated systematic review and meta-analysis

BACKGROUND: The T2-fluid-attenuated inversion recovery (FLAIR) mismatch sign, has been considered a highly specific imaging biomarker of IDH-mutant, 1p/19q noncodeleted low-grade glioma. This systematic review and meta-analysis aimed to evaluate the diagnostic performance of T2-FLAIR mismatch sign f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Do, Yoon Ah, Cho, Se Jin, Choi, Byung Se, Baik, Sung Hyun, Bae, Yun Jung, Sunwoo, Leonard, Jung, Cheolkyu, Kim, Jae Hyoung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859831/ https://www.ncbi.nlm.nih.gov/pubmed/35198981 http://dx.doi.org/10.1093/noajnl/vdac010

Ejemplares similares

T2/FLAIR-mismatch sign for noninvasive detection of IDH-mutant 1p/19q non-codeleted gliomas: validity and pathophysiology
por: Foltyn, Martha, et al.
Publicado: (2020)

T(2)-FLAIR Mismatch Sign Is Caused by Long T(1) and T(2) of IDH-mutant, 1p19q Non-codeleted Astrocytoma
por: Kinoshita, Manabu, et al.
Publicado: (2020)

Impact of Inversion Time for FLAIR Acquisition on the T2-FLAIR Mismatch Detectability for IDH-Mutant, Non-CODEL Astrocytomas
por: Kinoshita, Manabu, et al.
Publicado: (2021)

Multi-Parametric Radiomic Model to Predict 1p/19q Co-Deletion in Patients with IDH-1 Mutant Glioma: Added Value to the T2-FLAIR Mismatch Sign
por: Kihira, Shingo, et al.
Publicado: (2023)

Quantitative relaxometry using synthetic MRI could be better than T2-FLAIR mismatch sign for differentiation of IDH-mutant gliomas: a pilot study
por: Kikuchi, Kazufumi, et al.
Publicado: (2022)

The T2-FLAIR Mismatch Sign as an Imaging Indicator of IDH-Mutant, 1p/19q Non-Codeleted Lower Grade Gliomas: A Systematic Review and Diagnostic Accuracy Meta-Analysis
por: Adamou, Antonis, et al.
Publicado: (2021)

The Role of the T2–FLAIR Mismatch Sign as an Imaging Marker of IDH Status in a Mixed Population of Low- and High-Grade Gliomas
por: Kapsalaki, Eftychia Z., et al.
Publicado: (2020)

Clinicopathological analysis of T2-FLAIR mismatch sign in lower-grade gliomas
por: Deguchi, Shoichi, et al.
Publicado: (2020)

NI-09 CLINICAL SIGNIFICANCE OF T2-FLAIR MISMATCH SIGN IN LOWER GRADE GLIOMAS
por: Deguchi, Shoichi, et al.
Publicado: (2019)

NI-17 T2-FLAIR MISMATCH SIGN IN DIFFUSE GLIOMA AND DYSEMBRYOPLASTIC NEUROEPITHELIAL TUMOR
por: Onishi, Shumpei, et al.
Publicado: (2019)

A Nationwide Web-Based Survey of Neuroradiologists’ Perceptions of Artificial Intelligence Software for Neuro-Applications in Korea
por: Choi, Hyunsu, et al.
Publicado: (2023)

The T2‐FLAIR mismatch sign as an imaging biomarker for oligodendrogliomas in dogs
por: Garcia‐Mora, Josefa, et al.
Publicado: (2023)

Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort
por: van Garderen, Karin A, et al.
Publicado: (2023)

Classification of true progression after radiotherapy of brain metastasis on MRI using artificial intelligence: a systematic review and meta-analysis
por: Kim, Hae Young, et al.
Publicado: (2021)

NI-10 T2/FLAIR mismatch sign and methionine PET uptake in grade II and III gliomas
por: Ebiko, Yusuke, et al.
Publicado: (2020)

A curious case of T2-FLAIR mismatch in H3K27M mutant glioma
por: Valentino, William L., et al.
Publicado: (2022)

The clinical significance of the T2-FLAIR mismatch sign in grade II and III gliomas: a population-based study
por: Corell, Alba, et al.
Publicado: (2020)

Mismatch repair–deficient glioma with spatially distinct IDH-mutant and IDH-wild type components arising in the setting of Lynch syndrome
por: Tan, Hao, et al.
Publicado: (2023)

Therapies for IDH-Mutant Gliomas
por: Alshiekh Nasany, Ruham, et al.
Publicado: (2023)

Differentiation of Deep Subcortical Infarction Using High-Resolution Vessel Wall MR Imaging of Middle Cerebral Artery
por: Bae, Yun Jung, et al.
Publicado: (2017)

Efficacy of Maximum Intensity Projection of Contrast-Enhanced 3D Turbo-Spin Echo Imaging with Improved Motion-Sensitized Driven-Equilibrium Preparation in the Detection of Brain Metastases
por: Bae, Yun Jung, et al.
Publicado: (2017)

NI-8 Molecular diagnostic prediction combining T2-FLAIR mismatch sign, calcification, and methionine PET in grade II and III gliomas
por: Ebiko, Yusuke, et al.
Publicado: (2021)

The T2-FLAIR mismatch sign in glioblastoma, isocitrate dehydrogenase wild-type A case report
por: Nishimura, Shunsuke, et al.
Publicado: (2023)

Amide Proton Transfer-weighted MRI in the Diagnosis of Major Salivary Gland Tumors
por: Bae, Yun Jung, et al.
Publicado: (2019)

Efficient diagnosis of IDH-mutant gliomas: 1p/19qNET assesses 1p/19q codeletion status using weakly-supervised learning
por: Kim, Gi Jeong, et al.
Publicado: (2023)

Brain metastasis detection using machine learning: a systematic review and meta-analysis
por: Cho, Se Jin, et al.
Publicado: (2020)

Image Findings of Acute to Subacute Craniocervical Arterial Dissection on Magnetic Resonance Vessel Wall Imaging: A Systematic Review and Proportion Meta-Analysis
por: Cho, Se Jin, et al.
Publicado: (2021)

Texture Analysis of Multi-Shot Echo-Planar Diffusion-Weighted Imaging in Head and Neck Squamous Cell Carcinoma: The Diagnostic Value for Nodal Metastasis
por: Park, Jung Hyun, et al.
Publicado: (2019)

Methylation and transcription patterns are distinct in IDH mutant gliomas compared to other IDH mutant cancers
por: Unruh, Dusten, et al.
Publicado: (2019)

Postoperative risk of IDH-mutant glioma–associated seizures and their potential management with IDH-mutant inhibitors
por: Drumm, Michael R., et al.
Publicado: (2023)

DWI-FLAIR Mismatch at MRI Versus Infarct-Penumbra Mismatch on CT Perfusion
por: Collard, Margaux, et al.
Publicado: (2019)

Mismatch repair protein mutations in isocitrate dehydrogenase (IDH)-mutant astrocytoma and IDH-wild-type glioblastoma
por: Richardson, Timothy E, et al.
Publicado: (2023)

Retrospective examination of pseudoprogression in IDH mutant gliomas
por: Wetzel, Ethan A, et al.
Publicado: (2023)

Stalled oligodendrocyte differentiation in IDH-mutant gliomas
por: Wei, Yanfei, et al.
Publicado: (2023)

Updates on the WHO diagnosis of IDH-mutant glioma
por: Reuss, David.E.
Publicado: (2023)

Genomic profiles of IDH-mutant gliomas: MYCN-amplified IDH-mutant astrocytoma had the worst prognosis
por: Lee, Kwanghoon, et al.
Publicado: (2023)

DDRE-12. HETEROGENOUS RESPONSE OF IDH-MUTANT AND IDH-WT GLIOMA TO NAMPT INHIBITION
por: Rahman, Masum, et al.
Publicado: (2021)

Insulator dysfunction and oncogene activation in IDH mutant gliomas
por: Flavahan, William A., et al.
Publicado: (2015)

Metabolic Reprogramming in Mutant IDH1 Glioma Cells
por: Izquierdo-Garcia, Jose L., et al.
Publicado: (2015)

Mutant IDH1 Promotes Glioma Formation In Vivo
por: Philip, Beatrice, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b6nfmnv1m40989fnqrcj9aaan8